1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALNYLAM PHARMACEUTICALS INC
Alnylam Pharmaceuticals Inc XNAS: ALNY

Alnylam Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Expensive Rocket
about

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the m...

Read More
462.30 1.76 (0.38%)
124.56% Gain from 52W Low
668.6K
XNAS Volume

XNAS 18 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Alnylam Pharmaceuticals Inc is scheduled for today, for the purpose of Jefferies Global Healthcare Conference See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Expensive Valuation
21.7 / 100
Momentum Score
Technically Moderately Bullish
60.1 / 100
Expensive Rocket These stocks are a favourite among investors due to their bullish nature, good technical aspects but they have bad valuation and medium financials. View Similar Embed DVM
Analyst Price Target
484
1Yr Price target upside is 5%
25 analysts

17

S

9

W

1

O

3

T

SWOT Analysis

Alnylam Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..